Response to Letter to the Editor, 'Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,' by Ibrahim et al.

Yoshino, Takayuki; Hsu, Yanzhi; Nasroulah, Federico

Response to Letter to the Editor, 'Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,' by Ibrahim et al.

Yoshino, Takayuki; Hsu, Yanzhi; Nasroulah, Federico.

Afiliación

Yoshino T; National Cancer Center Hospital East, Chiba, Japan. Electronic address: tyoshino@east.ncc.go.jp.
Hsu Y; Eli Lilly and Company, Bridgewater, NJ, USA.
Nasroulah F; Eli Lilly and Company, Buenos Aires, Argentina.

Eur J Cancer ; 92: 121-122, 2018 03.

Article en En | MEDLINE | ID: mdl-29433790

Asunto(s)

Anticuerpos Monoclonales; Antígeno Carcinoembrionario; Anticuerpos Monoclonales Humanizados; Neoplasias del Colon; Neoplasias Colorrectales; Humanos; Ramucirumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno Carcinoembrionario / Anticuerpos Monoclonales Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google